Kenya: Pharmacy Board Denies Recalling Anti-Malaria Drug

A child taking pills (file photo).

Nairobi — The Pharmacy and Poisons Board has refuted claims that it re called an anti-malaria drug from the Kenyan market.

According to the Board, Duo-Cotexcin is only under quarantine pending investigations after failing a quality test.

It explained that it is undertaking investigations to ascertain the suspected quality defect on a specific batch.

"No recall or withdrawal is being conducted for the above product. The Pharmacy and Poisons Board is undertaking investigations to ascertain the suspected quality defect on that specific batch No 160621."

See What Everyone is Watching

More From: Capital FM

Don't Miss

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.